The potential of D-dimer levels as a useful clinical marker of clotting state after the return of sinus rhythm

Future Cardiology

Volumn 2, Issue 1, 2006, Pages 55-61

  Hatzinikolaou Kotsakou, Eleni ^a   Hatseras, Dimitrios I ^a  

^a DEMOCRITUS UNIVERSITY OF THRACE   (Greece)

Author keywords

Atrial fibrillation; Cardioversion; Fibrin D dimer

Indexed keywords

D DIMER; WARFARIN;

ADULT; AGED; ARTICLE; BLOOD CLOTTING; CARDIOVERSION; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC VALUE; FEMALE; HEART ATRIUM CONTRACTION; HEART ATRIUM FIBRILLATION; HEART RHYTHM; HIGH RISK PATIENT; HUMAN; HYPERCOAGULABILITY; MALE; PATIENT IDENTIFICATION; PRIORITY JOURNAL; RISK FACTOR; RISK REDUCTION; SINUS RHYTHM; THROMBOEMBOLISM; THROMBOGENESIS;

EID: 33646551454     PISSN: 14796678     EISSN: 17448298     Source Type: Journal    
DOI: 10.2217/14796678.2.1.55     Document Type: Article

References (25)

1. Kumagai K, Fukunami M, Ohmori M, Kitabatake A, Kamada T, Hori, N: Increased intra-cardiovascular clotting in patients with chronic atrial fibrillation. J. Am. Coll Cardiol. 16, 377-380 (1990).
2. Gustafsson C, Blomback M, Britton M, Hamsten A, Svensson J: Coagulation factors and the increased risk of stroke in non-valvular atrial fibrillation. Stroke 21, 47-51 (1990).
3. Cerebral Embolism Task Force: Cardiogenic brain embolism. Arch. Neurol. 43, 71-84 (1986).
4. Van Gelder IC, Hagens VE, Bosker HA et al.: Rate control versus electrical cardioversion for persistent atrial fibrillation study group. A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation. N. Engl. J. Med. 5(347), 1830-1840 (2002).
5. Wolf PA, Dawber TR, Emerson T Jr. Kannel WB: Epidemiologic assessment of chronic atrial fibrillation and risk of stroke: the Framingham Study. Neurology 28, 973-977 (1978).
6. Manning WJ, Silverman DI, Gordon SPF, Krucholz HM, Douglas PS: Cardioversion from atrial fibrillation without prolonged anticoagulation using transesophageal echo to exclude atrial thrombi. N. Engl. J. Med. 328, 750-755(1993).
7. Grimm RA, Stewart WJ, Maloney JD et al.: Impact of electrical cardioversion for atrial fibrillation on left atrial appendage function and spontaneous echo contrast by simultaneous transesophageal echocardiography. J. Am. Coll. Cardiol. 22, 1359-1366 (1993).
8. Takahashi N, Seki A, Imataka K, Fujii J: Clinical features of paroxysmal atrial fibrillation: an observation of 94 patients. Jpn. Cirr. J. 22, 143-149 (1981).
9. Manning WJ, Silverman DI, Katz SE et al: Impaired left atrial mechanical function after cardioversion: relationship to the duration of atrial fibrillation. J. Am. Coll. Cardiol. 23, 1535-1540 (1994).
10. Lip GYH, Lowe GDO: Fibrin D-dimer: a useful clinical marker of thrombogenesis. Clin. Sci. 89, 205-214 (1995).
11. Igarashi Y, Kashimura, K, Makiyama Y, Sato T, Ojima K. Aizawa Y: Left atrial appendage dysfunction in chronic nonvalvular atrial fibrillation is significantly associated with an elevated level of brain natriuretic peptide and a prothrombotic state. Jpn. Circ. J. 65, 788-792 (2001).
12. Lip GYH, Lip P, Zarifis J et al.: Fibrin D-dimer and thrombomodulin as markers of thrombogenesis and platelet activation in atrial fibrillation. Effects of introducing ultra-low-dose warfarin and aspirin. Circulation 94, 425-431 (1996).
13. Feinberg WM, Cornel ES, Nightingale SD et al.: Relationship between prothrombin activation fragment F1.2 and international normalized ratio in patients with atrial fibrillation. Prevention in Atrial Fibrillation Investigators. Stroke 28 (6). 1101-1106 (1997).
14. Currie MS, Rao KM, Blazer DG, Cohen HJ: Age and functional correlations of markers of coagulation and inflammation in the elderly: functional implications of elevated crosslinked fibrin degradation products (D-dimers). J. Am. Geriatr. Soc. 42, 738-742 (1994).
15. Hager K, Platt D: Fibrin degeneration product concentrations (D-dimers) in the course of aging. Gerontology 41, 159-165 (1995).
16. Tardy B, Tardy-Poncet B, Viallon A et al: Evaluation of D-dimer Elisa test in elderly patients with suspected pulmonary embolism. Thromb. Haemost. 79, 38-41 (1998).
17. Lip GYH. Rumley A, Dunn F, Lowe G: Plasma fibrinogen and fibrin D-dimer levels in paroxysmal atrial fibrillation: effects of cardioversion to sinus rhythm. Int. J. Cardiol. 51, 245-251 (1995).
18. Kelly J, Rudd A, Lewis R, Hunt BJ: Plasma D-dimers in the diagnosis of venous thromboembolism. Arch. Int. Med. 162, 747-756 (2002).
19. Lowe GDO, Rumely A, Yarnell JWG, Sweetnam PM, Thomas HF: Fibrin D-dimer, von-Willebrand factor and tissue plasminogen activator antigens are predictors of major ischaemic heart disease: the Caerphilly Study. Blood Coag. Fibrinol. 6, 156-157 (1995).
20. Woodburn K, Lowe G, Rumely A, Love J, Pollock J: Relation of hemostatic, fibrinolytic, and rheological variables to the angiographic extent of peripheral arterial occlusive disease. Int. Angiol. 14, 346-352 (1955).
21. Escoffre-Barbe M, Oger E, Leroyer C et al.: Evaluation of a new rapid D-dimer assay for clinically suspected deep venous thrombosis. Am. J. Clin. Pathol. 109, 748-753 (1998).
22. Kumagai K, Fukunami M, Ohmori M, Kitabatake A, Kamada T, Hoki N: Increased intracardiovascular clotting in patients with atrial fibrillation. J. Am. Coll. Cardiol. 16, 377-380 (1990).
23. Lip GY: The prothrombotic state in atrial fibrillation: new insights, more questions, and clear answers needed. Am. Heart J. 140, 348-350 (2000).
24. Heppell RM, Berkin KE, McLenechan JM, Davies JA: Haemostatic and haemodynamic abnormalities associated with left atrial thrombus in non-rheumatic atrial fibrillation. Heart 77, 407-411 (1997).
25. Manning WJ, Leeman DE, Gotch PJ et al: Pulsed Doppler evaluation of atrial mechanical function after electrical cardioversion of atrial fibrillation. J. Am. Coll. Cardiol. 13, 617-623 (1989).